Aptamers in cancer therapy: Why has clinical translation lagged behind preclinical promise? [PDF]
Tran TT +7 more
europepmc +1 more source
Quantitative oncogene-mapping within malignant tumors through Multi-parameter MRI based on RNA-triggered nanoprobes. [PDF]
Li W +8 more
europepmc +1 more source
Development of AS1411 aptamer-conjugated chitosan-carbon dot nanocarriers for targeted drug delivery and fluorescent imaging in breast cancer therapy. [PDF]
Mantashlou MJ +4 more
europepmc +1 more source
Fulfilling multiple roles in PROTAC design: The emerging potential of oligonucleotides. [PDF]
Rodrigues DA +4 more
europepmc +1 more source
Amelioration of colorectal cancer-associated fibroblasts in immunosuppressive microenvironment by ferroptosis-based nanotherapy. [PDF]
Wang S +7 more
europepmc +1 more source
Therapeutic Potential of Peptides in Cancer Treatment: Focus on Peptide and Aptamer-Decorated Exosomes. [PDF]
Gangadaran P +14 more
europepmc +1 more source
Synthesis and Evaluation of AS1411-Lenalidomide-Targeted Degradation Chimera in Antitumor Therapy. [PDF]
Ma X +11 more
europepmc +1 more source
A DNA nanoflowers-based microneedle patch for transdermal gene and photodynamic therapy against melanoma. [PDF]
Qi Y +10 more
europepmc +1 more source
Research advances in aptamers in the diagnosis and treatment of breast cancer (Review). [PDF]
Chu L +6 more
europepmc +1 more source
Human Serum Albumin as a Prodrug Carrier for Tumor Therapy: Mechanisms, Applications, and Future Perspectives. [PDF]
Shang Y +5 more
europepmc +1 more source

